Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study

Blood (2024) 144 (9): 1001–1009.

https://doi.org/10.1182/blood.2023023525

Published: 2024

Includes: Supplemental data

Journal Articles

Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway

Joshua P.P. Entrop, Caroline E. Weibull, Karin E. Smedby, Lasse Hjort Jakobsen, Andreas K. Oevlisen, Ingrid Glimelius, Anna Marklund, Thomas S. Larsen, Harald Holte, Alexander Fosså, Knut B. Smeland, Tarec Christoffer Christoffer El-Galaly, Sandra Eloranta

Blood (2022) 140 (Supplement 1): 1079–1081.

https://doi.org/10.1182/blood-2022-155919

Published: 2022

Journal Articles

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Blood (2022) 140 (Supplement 1): 1921–1923.

https://doi.org/10.1182/blood-2022-164692

Published: 2022

Journal Articles

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma

Blood (2022) 140 (Supplement 1): 2292–2295.

https://doi.org/10.1182/blood-2022-157194

Published: 2022

Journal Articles

A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21 R110

Blood (2022) 140 (Supplement 1): 1800–1802.

https://doi.org/10.1182/blood-2022-165181

Published: 2022

Journal Articles

Sex Differences in Lymphoma Incidence and Excess Mortality By Subtype: A Comprehensive National Study

Cecilia Radkiewicz, Johanna Borg Bruchfeld, Caroline Weibull, Mats Lambe, Lasse H. Jakobsen, Tarec Christoffer El-Galaly, Karin E. Smedby, Tove Wästerlid

Blood (2021) 138 (Supplement 1): 2534.

https://doi.org/10.1182/blood-2021-146604

Published: 2021

Journal Articles

Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in Harmony

Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Manja Meggendorfer, Ferran Nadeu, Christian Brieghel, Helen Parker, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana E Rodríguez-Vicente, Rocio Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquin Martinez-Lopez, Javier de la Serna, Jesús M Hernández Rivas, Patrick Thornton, Maria Jose Larrayoz, María José Calasanz, Zoltán Mátrai, Csaba Bodor, Karin E. Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, María José Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Ken I Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elías Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist

Blood (2021) 138 (Supplement 1): 2617.

https://doi.org/10.1182/blood-2021-150648

Published: 2021

Journal Articles

Late Effects after Treatment in Mantle Cell Lymphoma: No Difference By Intensity of First-Line Regimens with or without Autologous Stem Cell Transplantation

Sara Ekberg, Karin E. Smedby, Alexandra Albertsson-Lindblad, Mats Jerkeman, Caroline Weibull, Ingrid Glimelius

Blood (2021) 138 (Supplement 1): 1344.

https://doi.org/10.1182/blood-2021-145450

Published: 2021

Journal Articles

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Caroline Weibull, Björn E Wahlin, MD PhD, Sandra Lockmer, Gunilla Enblad, Per-Ola Andersson, MD PhD, Eva Kimby, MD PhD, Karin E. Smedby, MD PhD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-140228

Published: 2020

Journal Articles

Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL C omplete Project

Mats Jerkeman, MD PhD, Thorgerdur Palsdottir, Ingrid Glimelius, MD PhD, Alexandra Albertsson-Lindblad, MD PhD, Caroline Weibull, Fredrik Ellin, MD PhD, Kristina Sonnevi, MD PhD, Catharina Lewerin, MD PhD, Lena Brandefors, Karin E. Smedby, MD PhD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-133292

Published: 2020

Journal Articles

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Blood (2020) 135 (21): 1859–1869.

https://doi.org/10.1182/blood.2019003453

Published: 2020

Includes: Supplemental data

Journal Articles

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, MD Professor, Sverker Hasselblom, Björn E Wahlin, MD PhD, Per-Ola Andersson, MD PhD, Karin E. Smedby, MD PhD

Blood (2019) 134 (Supplement_1): 399.

https://doi.org/10.1182/blood-2019-122014

Published: 2019

Journal Articles

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Ingrid Glimelius, MD PhD, Karin E. Smedby, MD PhD, Alexandra Albertsson-Lindblad, MD PhD, Sandra Eloranta, Mats Jerkeman, MD Professor, Caroline Weibull

Blood (2019) 134 (Supplement_1): 4572.

https://doi.org/10.1182/blood-2019-124676

Published: 2019

Journal Articles

Encouraging Outcomes with Intensive Chemotherapy for Patients with Primary Mediastinal B-Cell Lymphoma - a Swedish Lymphoma Register Study

Tove Wästerlid, MD PhD, George Z. Rassidakis, MD PhD Prof., Birgitta Sander, MD PhD Prof., Karin E. Smedby, MD PhD

Blood (2019) 134 (Supplement_1): 1618.

https://doi.org/10.1182/blood-2019-122819

Published: 2019

Journal Articles

Clinical Characteristics and Outcomes Among Very Elderly Patients with Major Lymphoma Subtypes: A Nordic Lymphoma Group Study

Tove Wästerlid, MDPhD, Kim Gradel, PhD, Mats Jerkeman, Henrik Frederiksen, MD PhD, Karin E Smedby, MDPhD

Blood (2018) 132 (Supplement 1): 571.

https://doi.org/10.1182/blood-2018-99-114012

Published: 2018

Journal Articles

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Sverker Hasselblom, Björn E Wahlin, Per-Ola Andersson, Karin E Smedby

Blood (2018) 132 (Supplement 1): 2975.

https://doi.org/10.1182/blood-2018-99-110672

Published: 2018

Journal Articles

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Blood (2018) 131 (23): 2541–2551.

https://doi.org/10.1182/blood-2017-11-814608

Published: 2018

Includes: Supplemental data

Journal Articles

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Blood (2017) 130 (Supplement 1): 57.

https://doi.org/10.1182/blood.V130.Suppl_1.57.57

Published: 2017

Journal Articles

Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs

Fredrik Ellin, MD MSc, Matthew J Maurer, MS, Line Srour, MD, Umar Farooq, MD, Mats Jerkeman, MD PhD, Joseph M Connors, MD, Karin E Smedby, MD PhD, Nabila Nora Bennani, MD, Stephen M Ansell, MD PhD, Graham W Slack, MD, James R. Cerhan, MD PhD, Thomas Relander, MD PhD, Andrew L Feldman, MD, Kerry J Savage, BSc, MD MSc

Blood (2017) 130 (Supplement 1): 2795.

https://doi.org/10.1182/blood.V130.Suppl_1.2795.2795

Published: 2017

Journal Articles

Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia

Caroline Besson, MDPhD, Amy Moore, Wenting Wu, Nicola J Camp, PhD, Claire Vajdic, Lindsay M. Morton, PhD, Karin E Smedby, MD PhD, Silvia de Sanjose, Tait D Shanafelt, MD, Jerry Brewer, Lydia Zablotska, Eric A. Engels, MD MPH, James R. Cerhan, MD PhD, Susan L Slager, PhD, Jiali Han, Sonja I Berndt, PhD

Blood (2017) 130 (Supplement 1): 1454.

https://doi.org/10.1182/blood.V130.Suppl_1.1454.1454

Published: 2017

NARROW

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study

Reproduktiv Patterns Among Non-Hodgkin Lymphoma Survivors By Subtype in Sweden, Denmark and Norway

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

FLIPI24: An Improved International Prognostic Model Developed on Early Events in Follicular Lymphoma

A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21 R110

Sex Differences in Lymphoma Incidence and Excess Mortality By Subtype: A Comprehensive National Study

Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in Harmony

Late Effects after Treatment in Mantle Cell Lymphoma: No Difference By Intensity of First-Line Regimens with or without Autologous Stem Cell Transplantation

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL C omplete Project

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Encouraging Outcomes with Intensive Chemotherapy for Patients with Primary Mediastinal B-Cell Lymphoma - a Swedish Lymphoma Register Study

Clinical Characteristics and Outcomes Among Very Elderly Patients with Major Lymphoma Subtypes: A Nordic Lymphoma Group Study

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs

Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only